Cournoyer Quoted on Medicare Advantage Expansion in Bloomberg Law


Andrew Cournoyer, vice president at Precision for Value, offers an initial reaction to CMS’s new flexibility on offering benefits and controlling costs, which are expected to grow the Medicare Advantage program. He notes the cost benefits recognized by plans could have a ripple effect in reduced premiums.

To read the article, please click link below.

Reproduced with permission from BNA’s Health Insurance Report, 24 HPPR 8 (Feb. 21, 2018). Copyright 2018 by The Bureau of National Affairs, Inc. (800-372-1033) <>

Bloomberg Law – Medicare Managed Care Growth Expected to Take Offf

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.